Cyclocreatine treatment ameliorates the cognitive, autistic and epileptic phenotype in a mouse model of Creatine Transporter Deficiency

Creatine Transporter Deficiency (CTD) is an inborn error of metabolism presenting with intellectual disability, behavioral disturbances and epilepsy. There is currently no cure for this disorder. Here, we employed novel biomarkers for monitoring brain function, together with well-established behavio...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Sci Rep
Päätekijät: Cacciante, Francesco, Gennaro, Mariangela, Sagona, Giulia, Mazziotti, Raffaele, Lupori, Leonardo, Cerri, Elisa, Putignano, Elena, Butt, Mark, Do, Minh-Ha T., McKew, John C., Alessandrì, Maria Grazia, Battini, Roberta, Cioni, Giovanni, Pizzorusso, Tommaso, Baroncelli, Laura
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Publishing Group UK 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7591530/
https://ncbi.nlm.nih.gov/pubmed/33110151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-75436-4
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia